The authors of the discovery were scientists from Queen Mary University of London, reports runews24.ru.
As a result, the body's natural defense against the development of atherosclerosis increases, the authors of the study explained.
Thus, tests on mice have shown that when Vt4 is administered to subjects with progressive atherosclerosis and arthritis, the total cholesterol level decreases and the concentration of HDL-related cholesterol increases.
This helps to find an explanation for why patients with rheumatoid arthritis are more likely to develop blood vessel diseases.
